Showing results (671-680 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|April 3, 2023
Case report: crowned dens syndrome in a patient with seronegative rheumatoid arthritisGianfranco Ferraccioli, Romeo Zanardi, Elisa Gremese
RMD Open|April 20, 2021
ANCA-associated renal vasculitis is associated with rurality but not seasonality or deprivation in a complete national cohort studyOshorenua Aiyegbusi, Marina Frleta-Gilchrist, Jamie P Traynor, et al.
RMD Open|October 25, 2022
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flaresFrancesco Carubbi, Alessia Alunno, Jessica Santilli, et al.
RMD Open|September 14, 2022
Remote self-collection of capillary blood using upper arm devices for autoantibody analysis in patients with immune-mediated inflammatory rheumatic diseasesJoshua Zarbl, Ekaterina Eimer, Camilla Gigg, et al.
RMD Open|September 15, 2022
Impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registryCasper Webers, Astrid van Tubergen, Harald E Vonkeman, et al.
RMD Open|September 15, 2022
Impact of febuxostat on visit-to-visit blood pressure variability: insights from the randomised PRIZE StudyYuichi Saito, Atsushi Tanaka, Yuji Koide, et al.
RMD Open|September 16, 2022
Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohortMarie-Elise Truchetet, Elodie Drumez, Thomas Barnetche, et al.
RMD Open|September 27, 2022
Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosisSongxin Yan, Yu Peng, Ziyan Wu, et al.
RMD Open|September 28, 2022
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritisLaura C Coates, Josef S Smolen, Philip J Mease, et al.
RMD Open|September 19, 2022
Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosusPhilippe Mertz, Matteo Piga, Elisabetta Chessa, et al.
Pageof 197